New hope for treatment of respiratory involvement following COVID-19 by bromhexine
Main Authors: | Abdolrazagh Barzegar, Masoud Ghadipasha, Nima Rezaei, Mehdi Forouzesh, Rohollah Valizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2021-05-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | https://jnephropharmacology.com/PDF/npj-10352 |
Similar Items
-
Blocking serine protease (TMPRSS2) by Bromhexine; looking at potential treatment to prevent COVID-19 infection
by: Ramin Tolouian, et al.
Published: (2020-07-01) -
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
by: Khalil Ansarin, et al.
Published: (2020-09-01) -
Variations in levels of ACE2 and TMPRSS2 receptors among COVID-19
by: Dalia Zanaty, et al.
Published: (2024-02-01) -
Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials
by: S. Bahadoram, et al.
Published: (2022-05-01) -
Eye Washing Downregulated Angiotensin-Converting Enzyme 2 in Conjunctival Tissue Samples from Smokers
by: Hiroshi Fujishima, et al.
Published: (2023-12-01)